No CrossRef data available.
Article contents
The role of adiposity, adipokines and polymorphisms of leptin and adiponectin in myelodysplastic syndromes
Published online by Cambridge University Press: 19 October 2023
Abstract
The aim of the present study was to investigate the relationship between leptin and adiponectin gene polymorphisms, circulating levels of leptin and adiponectin, adiposity and clinical markers in patients with myelodysplastic syndrome (MDS). This cross-sectional study was conducted with 102 adults and elderly MDS patients and 102 age- and sex-matched controls. Clinical characteristics, co-morbidities, anthropometric data, laboratory evaluation and genetic analysis (polymorphisms −2548G > A/rs7799039 of the LEP gene and +276G > T/rs1501299 of the ADIPOQ gene) were investigated. Serum leptin was higher and adiponectin lower in MDS when compared with controls. There was a significant positive correlation between serum leptin levels and BMI (r = 0·264, P = 0·025), waist circumference (r = 0·235, P = 0·047), body fat percentage (BF %) (r = 0·373, P = 0·001) and the fat mass index (FMI) (r = 0·371, P < 0·001). A lower mean adiponectin was found among patients with high BF %, higher visceral adiposity index and metabolic syndrome. A significant association was found between the AA genotype (mutant) of the LEP polymorphism rs7799039 and male sex and blast excess (≥ 5 %). In addition, a significant association was observed between the TT genotype (mutant) of the ADIPOQ rs1501299 polymorphism and Fe overload. These results demonstrate the importance of a comprehensive and systematic evaluation in patients with MDS in order to identify and control negative factors not related to the disease at an early stage.
- Type
- Research Article
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of The Nutrition Society
References
Ministry of Health (2019) Vigitel Brazil 2018. Surveillance of Risk and Protective Factors for Chronic Diseases by Telephone Survey. Brasília: Ministry of Health.Google Scholar
Kyrgiou, M, Kalliala, I, Markozannes, G, et al. (2017) Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356, j477.CrossRefGoogle ScholarPubMed
Poynter, JN, Richardson, M, Blair, CK, et al. (2016) Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiol 40, 134–140.CrossRefGoogle ScholarPubMed
Adler, BJ, Kaushansky, K & Rubin, CT (2014) Obesity-driven disruption of haematopoiesis and the bone marrow niche. Nat Rev Endocrinol 10, 737–748.CrossRefGoogle ScholarPubMed
Dalamaga, M, Chou, SH, Shields, K, et al. (2013) Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell Metab 18, 29–42.CrossRefGoogle ScholarPubMed
Marinou, K, Tousoulis, D, Antonopoulos, AS, et al. (2010) Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol 138, 3–8.CrossRefGoogle ScholarPubMed
Esfahani, M, Movahedian, A, Baranchi, M, et al. (2015) Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci 18, 430–442.Google ScholarPubMed
Spyrou, N, Avgerinos, KI, Mantzoros, CS, et al. (2018) Classic and novel adipocytokines at the intersection of obesity and cancer: diagnostic and therapeutic strategies. Curr Obes Rep 7, 260–275.CrossRefGoogle ScholarPubMed
Ray, A & Cleary, MP (2017) The potential role of leptin in tumor invasion and metastasis. Cytokine Growth Factor Rev 38, 80–97.CrossRefGoogle ScholarPubMed
Ghasemi, A, Saeidi, J, Azimi-Nejad, M, et al. (2019) Leptin-induced signaling pathways in cancer cell migration and invasion. Cell Oncol 42, 243–260.CrossRefGoogle ScholarPubMed
Tsiotra, PC, Pappa, V, Koukourava, A, et al. (2005) Expression of leptin receptors in mononuclear cells from myelodysplastic syndromes and acute myeloid leukemias. Acta Haematol 114, 71–77.CrossRefGoogle ScholarPubMed
Dalamaga, M, Nikolaidou, A, Karmaniolas, K, et al. (2007) Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study. Oncology 73, 26–32.CrossRefGoogle ScholarPubMed
Dalamaga, M, Karmaniolas, K, Nikolaidou, A, et al. (2008) Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Eur J Cancer 44, 1744–1753.CrossRefGoogle ScholarPubMed
Han, TJ & Wang, X (2015) Leptin and its receptor in hematologic malignancies. Int J Clin Exp Med 8, 19840–19849.Google ScholarPubMed
He, J, Xi, B, Ruiter, R, et al. (2013) Association of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: evidence from a meta-analysis. PLoS ONE 8, 1–12.Google ScholarPubMed
Lee, JY, Cho, JK, Hong, HR, et al. (2012) Genetic effects of adiponectin single nucleotide polymorphisms on the clustering of metabolic risk factors in young Korean adults. Eur J Appl Physiol 112, 623–629.CrossRefGoogle ScholarPubMed
Oliveira, SC, Saddi-Rosa, P, Crispim, F, et al. (2012) Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. J Diabetes Complications 26, 94–98.CrossRefGoogle ScholarPubMed
Zayani, N, Omezzine, A, Boumaiza, I, et al. (2017) Association of ADIPOQ, leptin, LEPR, and resistin polymorphisms with obesity parameters in Hammam Sousse Sahloul Heart Study. J Clin Lab Anal 31, 1–10.CrossRefGoogle ScholarPubMed
Arber, DA, Orazi, A, Hasserjian, R, et al. (2016) The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood 127, 2391–2405.CrossRefGoogle Scholar
Greenberg, PL, Tuechler, H, Schanz, J, et al. (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120, 2454–2465.CrossRefGoogle ScholarPubMed
World Health Organization Expert Committee (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 854, 1–452.Google Scholar
World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894, 1–253.Google Scholar
Durnin, JV & Womersley, J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32, 77–97.CrossRefGoogle ScholarPubMed
Harrison, GG, Buskirk, ER, Carter, LJE, et al. (1988) Skinfold thicknesses and measurement technique. In Anthropometric Standardization Reference Manual, pp. 55–70 [Lohman, TG, Roche, AF and Martorell, R, editors]. Champaign: Human Kinetics Books.Google Scholar
Lohman, TG (1992) Advances in Body Composition Assessment. Current Issues in Exercise Science Series (Monograph 3). Champaign, IL: Human Kinetics.Google Scholar
Van Itallie, TB, Yang, MU, Heymsfield, SB, et al. (1990) Height-normalized indices of the body’s fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 52, 953–959.CrossRefGoogle ScholarPubMed
Kelly, TL, Wilson, KE & Heymsfield, SB (2009) Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS ONE 4, e7038.CrossRefGoogle ScholarPubMed
Amato, MC, Giordano, C & Galia, M (2010) Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33, 920–922.CrossRefGoogle ScholarPubMed
Amato, MC, Giordano, C, Pitrone, M, et al. (2011) Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 10, 183.CrossRefGoogle Scholar
National Cholesterol Education Program (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Anon expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285, 2486–2497.CrossRefGoogle Scholar
Clarke, GM, Anderson, CA & Pettersson, FH (2011) Basic statistical analysis in genetic case-control studies. Nat Protoc 6, 121–133.CrossRefGoogle Scholar
Hosney, M, Sabet, S, El-Shinawi, M, et al. (2017) Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer. Exp Ther Med 13, 2235–2246.CrossRefGoogle ScholarPubMed
Geng, Y, Wang, J, Wang, R, et al. (2012) Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients. Biomed Pharmacother 66, 419–424.CrossRefGoogle ScholarPubMed
Wang, D, Gao, L, Gong, K, et al. (2017) Increased serum leptin level in overweight patients with colon carcinoma: a cross-sectional and prospective study. Mol Clin Oncol 6, 75–78.CrossRefGoogle ScholarPubMed
Wang, PP, He, XY, Wang, R, et al. (2014) High leptin level is an independent risk factor of endometrial cancer: a meta-analysis. Cellular Physiol Biochem 34, 1477–1484.CrossRefGoogle ScholarPubMed
Aref, S, Ibrahim, L, Azmy, E, et al. (2013) Impact of serum adiponectin and leptin levels in acute leukemia. Hematology 18, 198–203.CrossRefGoogle ScholarPubMed
Konopleva, M, Mikhail, A, Estrov, Z, et al. (1999) Expression and function of leptin receptor isoforms in myeloid leucemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 93, 1668–1676.CrossRefGoogle Scholar
Mantzoros, C, Petridou, E, Dessypris, N, et al. (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89, 1102–1107.CrossRefGoogle ScholarPubMed
Wei, EK, Giovannucci, E, Fuchs, CS, et al. (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97, 1688–1694.CrossRefGoogle ScholarPubMed
Petridou, E, Mantzoros, C, Dessypris, N, et al. (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88, 993–997.CrossRefGoogle ScholarPubMed
Ishikawa, M, Kitayama, J, Kazama, S, et al. (2005) Plasma adiponectin and gastric cancer. Clin Cancer Res 11, 466–472.CrossRefGoogle ScholarPubMed
Arano, T, Nakagawa, H, Tateishi, R, et al. (2011) Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer 129, 2226–2235.CrossRefGoogle ScholarPubMed
Stolzenberg-Solomon, RZ, Weinstein, S, Pollak, M, et al. (2008) Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol 168, 1047–1055.CrossRefGoogle ScholarPubMed
Barb, D, Williams, CJ, Neuwirth, AK, et al. (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86, S858–S866.CrossRefGoogle ScholarPubMed
Lang, K & Ratke, J (2009) Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun and Signal 7, 27.CrossRefGoogle ScholarPubMed
Wang, Y, Lam, KSL & Xu, A (2007) Adiponectin as a negative regulator in obesity-related mammary carcinogenesis. Cell Res 17, 280–282.CrossRefGoogle ScholarPubMed
Azadniv, M, Myers, JR, McMurray, HR, et al. (2020) Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia 34, 391–403.CrossRefGoogle ScholarPubMed
Halaas, JL, Gajiwala, KS, Maffei, M, et al. (1995) A plasma protein encoded by the obese gene. Science 269, 543–546.CrossRefGoogle ScholarPubMed
Izquierdo, AG, Crujeiras, AB, Casanueva, FF, et al. (2019) Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients 11, e2704.CrossRefGoogle ScholarPubMed
Stachowicz, M, Mazurek, U, Nowakowska-Zajdel, E, et al. (2010) Leptin and its receptors in obese patients with colorectal cancer. J Biol Regul Homeost Agents 24, 287–295.Google ScholarPubMed
Singh, SK, Grifson, JJ, Mavuduru, RS, et al. (2010) Serum leptin: a marker of prostate cancer irrespective of obesity. Cancer Biomark 7, 11–15.CrossRefGoogle ScholarPubMed
Pan, H, Deng, LL, Cui, JQ, et al. (2018) Association between serum leptin levels and breast cancer risk: an updated systematic review and meta-analysis. Medicine 97, e11345.CrossRefGoogle ScholarPubMed
Awede, B, Adovoekpe, D, Adehan, G, et al. (2018) Adiponectin, in contrast to leptin, is not associated with body mass index, waist circumference and HOMA-IR in subjects of a west-African population. Physiol Rep 6, e13718.CrossRefGoogle Scholar
Ayina, CN, Noubiap, JJ, Etoundingoa, LS, et al. (2016) Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population. Lipids Health Dis 15, 96.CrossRefGoogle Scholar
Moon, HS, Dalamaga, M, Kim, SY, et al. (2013) Leptin’s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev 34, 377–412.CrossRefGoogle ScholarPubMed
Hu, S, Gan, C, Wen, R, et al. (2014) Role of leptin in the regulation of sterol/steroid biosynthesis in goose granulosa cells. Theriogenology 82, 677–685.CrossRefGoogle ScholarPubMed
Srivastava, R, Batra, A, Tyagi, A, et al. (2015) Adiponectin correlates with obesity: a study of 159 childhood acute leukemia survivors from India. Indian J Cancer 52, 195–197.Google ScholarPubMed
Obeid, S & Hebbard, L (2012) Role of adiponectin and its receptors in cancer. Cancer Biol Med 9, 213–220.Google ScholarPubMed
Roberts, DL, Dive, C & Renehan, AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61, 301–316.CrossRefGoogle ScholarPubMed
Mihu, D, Ciortea, R & Mihu, CM (2013) Abdominal adiposity through adipocyte secretion products, a risk factor for endometrial cancer. Gynecol Endocrinol 29, 448–451.CrossRefGoogle ScholarPubMed
Serretta, V, Abrate, A, Siracusano, S, et al. (2018) Clinical and biochemical markers of visceral adipose tissue activity: body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy. Urol Ann 10, 280–286.CrossRefGoogle ScholarPubMed
Aguiar, APN, Mendonça, PDS, Ribeiro-Júnior, HL, et al. (2020) Myelodysplastic syndromes: an analysis of non-hematological prognostic factors and its relationship to age. J Geriatr Oncol 11, 125–127.CrossRefGoogle ScholarPubMed
Cho, SA, Joo, HJ, Cho, JY, et al. (2017) Visceral fat area and serum adiponectin level predict the development of metabolic syndrome in a community-based asymptomatic population. PLoS ONE 12, e0169289.CrossRefGoogle Scholar
Tang, W, Kang, M, Liu, C, et al. (2019) Leptin rs7799039 (G2548A) polymorphism is associated with cancer risk: a meta-analysis involving 25,799 subjects. Onco Targets Ther 12, 2879–2890.CrossRefGoogle Scholar
Okpechi, IG, Rayner, BL, Van Der Merwe, L, et al. (2010) Genetic variation at selected SNPs in the leptin gene and association of alleles with markers of kidney disease in a Xhosa population of South Africa. PLoS ONE 5, 1–10.CrossRefGoogle Scholar
Gaukrodger, N, Mayosi, BM, Imrie, H, et al. (2005) A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. J Med Genet 42, 474–478.CrossRefGoogle ScholarPubMed
Fan, SH & Say, YH (2014) Leptin and leptin receptor gene polymorphisms and their association with plasma leptin levels and obesity in a multi-ethnic Malaysian suburban population. J Physiol Anthropol 33, 1–10.CrossRefGoogle Scholar
Hoffstedt, J, Eriksson, P, Mottagui-Tabar, S, et al. (2002) Polymorphism in the leptin promoter region (−2548 G/A) influences gene expression and adipose tissue secretion of leptin. Hormone Metab Res 34, 355–359.CrossRefGoogle ScholarPubMed
Hinuy, HM, Hirata, MH, Forti, N, et al. (2008) Leptin G-2548A promoter polymorphism is associated with increased plasma leptin and BMI in Brazilian women. Arq Bras Endocrinol Metabol 52, 611–616.CrossRefGoogle ScholarPubMed
Terrasi, M, Fiorio, E, Mercanti, A, et al. (2009) Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells. Int J Cancer 125, 1038–1044.CrossRefGoogle ScholarPubMed
Kaklamani, VG, Sadim, M, Hsi, A, et al. (2008) Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res 68, 3178–3184.CrossRefGoogle ScholarPubMed
Pei, Y, Xu, Y & Niu, W (2015) Causal relevance of circulating adiponectin with cancer: a meta-analysis implementing Mendelian randomization. Tumour Biol 36, 585–594.CrossRefGoogle Scholar
Kyriakou, T, Collins, LJ, Spencer-Jones, NJ, et al. (2008) Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet 53, 718–727.CrossRefGoogle ScholarPubMed
Xu, Y, He, B, Pan, Y, et al. (2013) The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep 40, 1135–1144.CrossRefGoogle ScholarPubMed
Ramya, K, Ayyappa, KA, Ghosh, S, et al. (2013) Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 532, 253–262.CrossRefGoogle ScholarPubMed
Alessandrino, EP, Della Porta, MG, Bacigalupo, A, et al. (2010) Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 95, 476–484.CrossRefGoogle ScholarPubMed
Yang, Y, Tang, Z, An, T, et al. (2019) The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: a meta-analysis. Medicine 98, e17406.CrossRefGoogle ScholarPubMed
Singer, P, Blaser, AR, Berger, MM, et al. (2019) ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 38, 48–79.CrossRefGoogle ScholarPubMed
Chen, S, Chen, Y, Liu, X, et al. (2014) Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine 46, 496–504.CrossRefGoogle ScholarPubMed